Recent trends in ovarian cancer incidence and relative survival in the United States by race/ethnicity and histologic subtypes

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 10, 2017, Pages 1511-1518

  Park, Hyo K ^a   Ruterbusch, Julie J ^a   Cote, Michele L ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; BLACK PERSON; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CARCINOSARCOMA; CAUCASIAN; CLEAR CELL CARCINOMA; COLLOID CARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY; UNITED STATES; VERY ELDERLY; ADOLESCENT; ANCESTRY GROUP; CHILD; ETHNIC GROUP; INCIDENCE; INFANT; MORTALITY; NEWBORN; OVARY TUMOR; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; OVARIAN NEOPLASMS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 85029869752     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-17-0290     Document Type: Article

References (28)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7–30.
2. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER website, April 2016.
3. Sopik V, Iqbal J, Rosen B, Narod SA. Why have ovarian cancer mortality rates declined? Part I. Incidence. Gynecol Oncol 2015;138:741–9.
4. Gnagy S, Ming EE, Devesa SS, Hartge P, Wittemore AS. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Epidemiology 2000;11:102–5.
5. Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008;371;303–14.
6. Mosher WD, Bachrach CA. Understanding U.S. fertility: continuity and change in the National Survey of Family Growth, 1988–1995. Fam Plann Perspect 1996;28:4–12.
7. Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006–2010, and changes in patterns of use since 1995. Natl Health Stat Report 2012;60:1–25.
8. Hamilton BE, Ventura SJ. Fertility and abortion rates in the United States, 1960–2002. Int J Androl 2006;29:34–45.
9. Li R, Grummer-Strawn L. Racial and ethnic disparities in breastfeeding among United States infants: Third National Health and Nutritional Examination Survey, 1988–1994. Birth 2002;29:251–7.
10. Kurian AW, Balise RR, McGuire V, Wittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 2005;96:520–30.
11. Modugno F, Ness RB, Wheeler JE. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 2001;11:568–74.
12. Wentzensen N, Poole EM, Trabert B, White E, Arsian AA, Patel AV, et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J Clin Oncol 2016;34;2888–98.
13. Mink PJ, Sherman ME, Devesa SS. Incidence patterns of invasive and borderline ovarian tumors among White women and Black women in the United States: results from the SEER Program, 1978–1998. Cancer 2002; 95:2380–9.
14. Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 2012;125:19–24.
15. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEERStat Database: Incidence - SEER 18 Regs Research DataþHurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (2000–2013) 'Katrina/Rita Population Adjustment'- Linked To County Attributes - Total U.S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission.
16. National Cancer Institute. Surveillance Epidemiology and End Results Program. About the SEER program. Available from: https://seer.cancer.gov/about/[accessed November 8, 2016].
17. Fritz A PC, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
18. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 2006;15:547–69.
19. Cho H, Howlader N, Mariotto AB, Cronin KA. Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. In: Surveillance Research Program NCI, editor. 2011.
20. Jacoby VL, Fujimoto VY, Guidice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol 2010;202:514–21.
21. Risch H, Marrett L, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case control study. Am J Epidemiol 1996;144:363–72.
22. Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol 2013;41:579–89.
23. Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies. Fertil Steril 2014;102:192–8.
24. Morris CR, Rodriguez AO, Epstein J, Cress RD. Declining trends of epithelial ovarian cancer in California. Gynecol Oncol 2008;108: 207–13.
25. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003; 27:985–93.
26. Kim SI, Lim MC, Lim J, Won YJ, Seo SS, Kang S, et al. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012. J Gynecol Oncol 2016;27:e5.
27. Chiang YC, Cheng CA, Chiang CJ, Hsu TH, Lin MC, You SL, et al. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol 2013;24: 342–51.
28. Teng Z, Han R, Huang X, Zhou J, Yang J, Luo P, et al. Increase of incidence and mortality of ovarian cancer during 2003–2012 in Jiangsu Province, China. Front Public Health 2016;4:e1–8.